Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical Trial of Helminth-induced Immunomodulatory Therapy (HINT 2) in Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
(-)
149
Authors/Disclosures
John O. Fleming, MD (University of Wisconsin, Madison)
PRESENTER
No disclosure on file
Edward J. Fine, MD, FÂé¶¹´«Ã½Ó³»­ (University Neurology, Northtowns) Dr. Fine has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Friends of PALS (People with ALS.
No disclosure on file
No disclosure on file
No disclosure on file
Christopher C. Luzzio, MD (University Wisconsin, Madison) No disclosure on file
Monica A. Koehn, MD, FÂé¶¹´«Ã½Ó³»­ (Marshfield Clinic) Dr. Koehn has nothing to disclose.
No disclosure on file
No disclosure on file
Benjamin E Lawler, MD (Marshfield Clinic) No disclosure on file
No disclosure on file
No disclosure on file
Loren A. Rolak, MD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file